Else Høibraaten

Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).

Else Høibraaten, Elisabeth Qvigstad, Harald Arnesen et al. · PubMed · 2000 · 264 citations

Hormonal Contraceptive, Gynecology, Pharmacotherapy +20

Increased Risk of Recurrent Venous Thromboembolism during Hormone Replacement Therapy

Erik Qvigstad, Harald Arnesen, Stig Larsen et al. · Thrombosis and Haemostasis · 2000 · 180 citations

Hormonal Contraceptive, Oral Contraceptive, Gynecology +20

Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double‐blind, placebo‐controlled trial

Else Høibraaten, Marie‐Christine Mowinckel, Hans de Ronde et al. · British Journal of Haematology · 2001 · 92 citations · Full text

Recurrent Vte, Hormonal Contraceptive, Oral Contraceptive +23

The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis

Anette Løken Eilertsen, Else Høibraaten, Ingrid Os et al. · Maturitas · 2005 · 60 citations

Inflammation, Thrombosis, Thrombopoiesis +12

Mechanisms of thrombosis related to hormone therapy

Per Morten Sandset, Else Høibraaten, Anette Løken Eilertsen et al. · Thrombosis Research · 2009 · 55 citations

Thrombopoiesis, Thrombosis, Blood Platelet +8